Method for replacing mitral valve

Patent metadata

Field	Value
Publication number	US-10226334-B2
Application number	US-201414584903-A
Country	US
Kind code	B2
Filing date	Dec 29, 2014
Priority date	May 1, 2008
Publication date	Mar 12, 2019
Grant date	Mar 12, 2019

Abstract

A method of implanting a prosthetic mitral valve assembly using a transapical procedure is disclosed. An incision is formed in the chest in the apex of the patient's heart. A delivery catheter containing the prosthetic mitral valve assembly is advanced over a guidewire into the patient's heart. The prosthetic mitral valve assembly is deployed from the delivery catheter into the native mitral valve. The prosthetic mitral valve assembly comprises a stent having a lower portion for placement between the leaflets of a native mitral valve and an upper portion having a flared end for placement above the annulus. The prosthetic mitral valve includes a valve portion having leaflets formed of pericardial tissue. A plurality of upwardly bent prongs are provided along an outer surface of the stent for preventing upward migration of the prosthetic mitral valve assembly after deployment.

First claim

We claim:

1. A prosthetic mitral valve assembly, comprising:
a self-expanding stent comprising an upper portion defining an inlet end of the stent having a first diameter, a lower portion defining an extreme outlet end of the stent having a second diameter, and an intermediate portion between the upper portion and the lower portion, the intermediate portion having a third diameter, the stent tapering from the inlet end to the intermediate portion and further tapering from the intermediate portion to the extreme outlet end such that the third diameter is less than the first diameter, and the second diameter is less than the third diameter, wherein the inlet end comprises a flared end sized to be positioned above an annulus of the native mitral valve, wherein the flared end is defined by a circumferentially extending row of struts that extends continuously around the entire extent of a circumference of the upper portion, wherein the flared end is sized such that when implanted, an atrial-most end of the prosthetic mitral valve assembly contacts supra-annular tissue continuously around the entire extent of a circumference of the upper portion;
a tether having a first end portion and a second end portion, the first end portion coupled to the lower portion of the stent, the tether being sized to extend through the left ventricle with the second end portion extending through a wall of the left ventricle at the apex of the heart; and
a tissue anchor connected to the second end portion of the tether and configured to be implanted against an outer surface of the left ventricle at the apex such that when the prosthetic mitral valve assembly is implanted, the tether resists migration of the stent in a direction toward the left atrium and the flared end of the stent resists migration of the stent in a direction toward the left ventricle;
wherein the prosthetic mitral valve assembly is held in place without clamping onto tissue of the annulus of the native mitral valve;
wherein the prosthetic mitral valve assembly is adapted to be advanced in a radially compressed state along a distal end of the delivery catheter for insertion through the wall of the heart.

2. The prosthetic mitral valve assembly of claim 1 , wherein the stent has a truncated conical shape.

3. The prosthetic mitral valve assembly of claim 1 , wherein the stent is made of nitinol.

4. The prosthetic mitral valve assembly of claim 1 , wherein the tether comprises a bioresorbable material.

5. The prosthetic mitral valve assembly of claim 1 , wherein the stent has a substantially D-shape cross-section for conforming to the native mitral valve.

6. The prosthetic mitral valve assembly of claim 1 , further comprising a valve portion having three prosthetic leaflets formed of porcine pericardium and mounted within an interior portion of the stent, the valve portion having leaflets for occluding blood flow in one direction and replacing the function of the native mitral valve.

7. The prosthetic mitral valve assembly of claim 6 , wherein the valve portion is mounted within the lower portion of the stent.

8. The prosthetic mitral valve assembly of claim 1 , wherein the tissue anchor comprises an enlarged head portion.

9. The prosthetic mitral valve assembly of claim 1 , wherein the stent has a length between 15 and 50 mm.

10. The prosthetic mitral valve assembly of claim 1 , wherein the stent has a continuous taper.

Assignees

• Edwards Lifesciences Corp

Inventors

• Rowe Stanton J
• Chau Mark
• Nguyen Son V

Classifications

• A61B17/0401

  Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors (A61B17/0642 takes precedence; fixation devices for tendons or ligaments A61F2/0811) · CPC title

• A61F2250/0039

  differing in diameter · CPC title

• A61L27/3625

  Vascular tissue, e.g. heart valves · CPC title

• A61F2220/0008

  Fixation appliances for connecting prostheses to the body · CPC title

• A61F2220/0016

  with sharp anchoring protrusions, e.g. barbs, pins, spikes · CPC title